Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database

INTRODUCTION: Since the first COVID-19 messenger RNA vaccines became available globally for emergency or conditional use, post-marketing surveillance activities have been implemented for the monitoring of any adverse events that might arise in daily clinical practice and were not detected earlier du...

Descripción completa

Detalles Bibliográficos
Autores principales: Santi Laurini, Greta, Montanaro, Nicola, Broccoli, Massimiliano, Bonaldo, Giulia, Motola, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043970/
https://www.ncbi.nlm.nih.gov/pubmed/37024412
http://dx.doi.org/10.1016/j.vaccine.2023.03.054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043970/
https://www.ncbi.nlm.nih.gov/pubmed/37024412
http://dx.doi.org/10.1016/j.vaccine.2023.03.054

Ejemplares similares